Update in Lawsuit for Investors who lost Money with shares of Instadose Pharma Corp. (OTC: INSD) announced by the Shareholders Foundation
11/29/2022 - 07:10 AM
SAN DIEGO, CA / ACCESSWIRE / November 29, 2022 / The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in Instadose Pharma Corp. (OTC PINK:INSD).
Investors, who purchased shares of Instadose Pharma Corp. prior to December 2020 and continue to hold any of those OTC: INSD shares, have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On December 20, 2021, a lawsuit was filed r certain investors in OTC: INSD shares against Instadose Pharma Corp. f/k/a Mikrocoze, Inc over alleged violations of securities laws. The plaintiff alleged that the Defendants made false and/or misleading statements and/or failed to disclose that Instadose had performed inadequate due diligence into the Business Combination and/or ignored significant red flags associated with Instadose Canada, that Instadose's internal controls and policies were inadequate to detect and/or prevent impermissible trading activity by control persons of the Company, that the foregoing subjected Instadose to a heightened risk of regulatory scrutiny and enforcement action, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
On August 24, 2022 the plaintiff requested an Entry of Default against the Defendants for failure to appear or respond in a timely manner to the Complaint.
On August 25, the Clerk of the court made an Entry of Default on the Docket as to both Defendants.
Those who purchased Instadose Pharma Corp. (OTC: INSD) shares should contact the Shareholders Foundation, Inc.
CONTACT:
Shareholders Foundation, Inc. mail@shareholdersfoundation.com
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.
SOURCE: Shareholders Foundation, Inc.
https://www.accesswire.com/729179/Update-in-Lawsuit-for-Investors-who-lost-Money-with-shares-of-Instadose-Pharma-Corp-OTC-INSD-announced-by-the-Shareholders-Foundation
INSD Rankings
N/A Ranked by Stock Gains
About INSD
instadose pharma corp. (“instadose”) is becoming the largest producer of cannabis oil in the world with a present projected cultivation capacity of over 2,250,000 kg of high-grade 97.0% isolate cbd and 92% isolate thc per year. global leader in cannabis production & commercial distribution of cannabinoid oil leading the disruption of the global cannabis industry by turning cannabis and cannabinoid oil into an insurable commodity exclusive right and license to grow, cultivate, and process (for export and sale) medical pharmaceutical cannabis in the drc 50-year partnerships with the newly elected drc government & the saccos (the region's largest farming co-operative) - gives instadose 1,000,000+ hectares (ha) of land in the aggregate for cannabis production & cultivation existing 5-year supply agreements for cannabinoid oil with leading global buyers generating usd$5b+ in revenue to instadose gmp certified & pharmaceutically accredited with eu pharmacopoeia standards talented and r
